| Synonyms: | |
| Status: | Approved (2010) |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 8S95DH25XC |
| InChI Key | ZNOVTXRBGFNYRX-STQMWFEESA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C20H25N7O6 |
| Molecular Weight | 459.46 |
| AlogP | -0.26 |
| Hydrogen Bond Acceptor | 9.0 |
| Hydrogen Bond Donor | 7.0 |
| Number of Rotational Bond | 9.0 |
| Polar Surface Area | 202.77 |
| Molecular species | ACID |
| Aromatic Rings | 2.0 |
| Heavy Atoms | 33.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Epigenetic regulator
Eraser
Histone deacetylase
HDAC class IIb
|
- | - | - | - | -1.23-11.09 | |
|
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | 1200 | - | |
|
Transporter
Primary active transporter
ATP-binding cassette
ABCC subfamily
|
- | - | - | 121000 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEBI | 15641 |
| ChEMBL | CHEMBL1231574 |
| DrugBank | DB04789 |
| DrugCentral | 4621 |
| EPA CompTox | DTXSID00185583 |
| FDA SRS | 8S95DH25XC |
| PDB | C2F |
| PharmGKB | PA166129561 |
| PubChem | 444412 |
| SureChEMBL | SCHEMBL79586 |
| ZINC | ZINC000002005305 |